Please login to the form below

Not currently logged in
Email:
Password:

The Purple Agency appoints Andrew Jenkins and Terri Martin

Jenkinsjoins from FTI Strategic Communications and Martin comes from Porterhouse

Purple Agency Terri Martin Andrew Jenkins 

UK healthcare communications company The Purple Agency has made two new senior hires, appointing Andrew Jenkins and Terri Martin.

Jenkins joins the Basingstoke-based agency from FTI Strategic Communications, where he was a senior vice president, and takes up a role as group account director within Purple's healthcare team.

Jenkins said: “Not only has Purple built up an enviable client base in the healthcare sector, but the range and scope of their work really is 'leading edge'. It will be a real pleasure to grow that client base and ensure that we continue to deliver exceptional communications programmes for our healthcare clients right across the world.” 

Meanwhile, Martin comes to the company from Reading-based Porterhouse Medical and will be an healthcare account director at Purple, which is part of the Adare group.

Steve Shaw, managing director of the Purple Agency, said: “Andrew and Terri both bring extensive specialist expertise to this rapidly expanding international sector of our business, which includes pioneering developments in digital communications for patients and clinicians. 

“They will both play a key role in developing existing accounts such as Novartis and GSK and, of course, to continuing to build our offering across a range of new accounts.” 

24th March 2015

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Frontera Group

Welcome to Frontera Group, where our agencies immerse you in the world of the patient...

Latest intelligence

What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...
Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...

Infographics